Directly conjugated antibodies for immunofluorescence

Find out more

Publishing research using ab8932? Please let us know so that we can cite the reference in this datasheet.

ab8932 has been referenced in 8 publications.

  • Xu L  et al. MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway. Mol Biol Cell 24:42-55 (2013). WB ; Mouse . PubMed: 23135998
  • Meyer S  et al. A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One 7:e38222 (2012). IHC-P . PubMed: 22685558
  • Cima I  et al. Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc Natl Acad Sci U S A 108:3342-7 (2011). IHC ; Human . PubMed: 21300890
  • Dupont J  et al. FSH-stimulated PTEN activity accounts for the lack of FSH mitogenic effect in prepubertal rat Sertoli cells. Mol Cell Endocrinol 315:271-6 (2010). PubMed: 19778579
  • Hager M  et al. Increased activated Akt expression in renal cell carcinomas and prognosis. J Cell Mol Med 13:2181-8 (2009). PubMed: 18774962
  • Jousan FD  et al. Short-Term culture of in vitro produced bovine preimplantation embryos with insulin-like growth factor-i prevents heat shock-induced apoptosis through activation of the Phosphatidylinositol 3-Kinase/Akt pathway. Mol Reprod Dev 75:681-8 (2008). IF ; Cow . PubMed: 18161856
  • Shah T  et al. Epidermal growth factor receptor expression and activation in neuroendocrine tumours. J Neuroendocrinol 18:355-60 (2006). PubMed: 16629834
  • Volanti C  et al. Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy. Oncogene 24:2981-91 (2005). PubMed: 15735712

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"